![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Daclatasvir in Combination With Simeprevir With or Without Ribavirin for
Hepatitis C Virus Genotype 1 Infection
|
|
|
Reported by Jules Levin
Conference on Retroviruses and Opportunistic Infections
Boston, MA, March 3-6, 2014
Zeuzem S,1 Hezode C,2 Bronowicki J-P,3 Loustaud-Ratti V,4 Gea F,5 Buti M,6 Beumont-Mauviel M,7 Boparai N,8 Picchio G,9 Noviello S,8 on behalf of the LEAGUE-1 Study Team
1JW Goethe University Hospital, Frankfurt, Germany; 2Hopital Henri Mondor, Paris, France; 3Centre Hospitalier Universitaire de Nancy, Vandoeuvre Les Nancy, France; 4Universite Limoges, Limoges, France; 5University Hospital La Paz, Madrid, Spain; 6Hospital Vall Hebron, Barcelona, Spain; 7Janssen Infectious Disease BVBA, Beerse, Belgium; 8Bristol-Myers Squibb, Princeton, NJ, USA; 9Janssen Research & Development, Titusville, NJ, USA
CROI webcast:
http://www.croiwebcasts.org/console/player/22172?mediaType=slideVideo&
![HCV1.gif](../images/030413/030414-6/HCV1.gif)
![HCV2.gif](../images/030413/030414-6/HCV2.gif)
![HCV3.gif](../images/030413/030414-6/HCV3.gif)
![HCV4.gif](../images/030413/030414-6/HCV4.gif)
![HCV5.gif](../images/030413/030414-6/HCV5.gif)
![HCV6.gif](../images/030413/030414-6/HCV6.gif)
![HCV7.gif](../images/030413/030414-6/HCV7.gif)
![HCV8.gif](../images/030413/030414-6/HCV8.gif)
![HCV9.gif](../images/030413/030414-6/HCV9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|